Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature. Reply to Dr. Ricceri letter
Author Information: Unit of Dermatology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.